Discoveries


Recent Discoveries Stories

A large clinical trial found that pairing eflornithine with lomustine helps people with recurrent grade 3 IDH-mutant astrocytoma live longer and delay tumor progression.
A new drug combination extends survival for patients with recurrent grade 3 astrocytoma, offering rare hope in aggressive brain cancer care.
Mac Oliveauupda